SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015483
Filing Date
2021-11-10
Accepted
2021-11-10 16:07:03
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20210930x10q.htm   iXBRL 10-Q 1245547
2 EX-31.1 armp-20210930xex31d1.htm EX-31.1 15433
3 EX-31.2 armp-20210930xex31d2.htm EX-31.2 15240
4 EX-32.1 armp-20210930xex32d1.htm EX-32.1 7894
5 EX-32.2 armp-20210930xex32d2.htm EX-32.2 8083
6 GRAPHIC armp-20210930x10q001.jpg GRAPHIC 39107
  Complete submission text file 0001558370-21-015483.txt   4928022

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20210930.xsd EX-101.SCH 39274
8 EX-101.CAL armp-20210930_cal.xml EX-101.CAL 35561
9 EX-101.DEF armp-20210930_def.xml EX-101.DEF 139290
10 EX-101.LAB armp-20210930_lab.xml EX-101.LAB 319327
11 EX-101.PRE armp-20210930_pre.xml EX-101.PRE 283009
12 EXTRACTED XBRL INSTANCE DOCUMENT armp-20210930x10q_htm.xml XML 660429
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 211396565
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences